Bernett; Matthew J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bernett; Matthew J..The latest application filed is for "heterodimeric antibodies that bind cd3 and gpc3".
Company Profile
16.47.67
- Bernett; Matthew J. - Monrovia CA
Patent Activity
| Patent | Date |
|---|---|
| Heterodimeric Antibodies That Bind Cd3 And Gpc3 App 20220306767 - Nisthal; Alex ; et al. | 2022-09-29 |
| ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS App 20220227867 - Bernett; Matthew J. ; et al. | 2022-07-21 |
| CTLA4-IG immunoadhesins Grant 11,352,412 - Lazar , et al. June 7, 2 | 2022-06-07 |
| Heterodimeric antibodies that bind CD3 and CD38 Grant 11,352,442 - Bernett , et al. June 7, 2 | 2022-06-07 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220162343 - Bernett; Matthew J. ; et al. | 2022-05-26 |
| TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS App 20220073588 - Bernett; Matthew J. ; et al. | 2022-03-10 |
| CTLA4-Ig immunoadhesins Grant 11,254,727 - Lazar , et al. February 22, 2 | 2022-02-22 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20220041757 - Bernett; Matthew J. ; et al. | 2022-02-10 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,225,528 - Bernett , et al. January 18, 2 | 2022-01-18 |
| HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS App 20210284754 - Bernett; Matthew J. ; et al. | 2021-09-16 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 11,111,315 - Bernett , et al. September 7, 2 | 2021-09-07 |
| Bispecific Immunomodulatory Antibodies That Bind Costimulatory And Checkpoint Receptors App 20210253706 - Bernett; Matthew J. ; et al. | 2021-08-19 |
| Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains Grant 11,084,863 - Bernett , et al. August 10, 2 | 2021-08-10 |
| Novel Ctla4-ig Immunoadhesins App 20210230250 - Lazar; Gregory A. ; et al. | 2021-07-29 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20210102003 - Bernett; Matthew J. ; et al. | 2021-04-08 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,913,803 - Bernett , et al. February 9, 2 | 2021-02-09 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,889,653 - Bernett , et al. January 12, 2 | 2021-01-12 |
| Bispecific antibodies that bind to CD38 and CD3 Grant 10,858,451 - Bernett , et al. December 8, 2 | 2020-12-08 |
| Heterodimeric human IgG1 polypeptides with isoelectric point modifications Grant 10,851,178 - Bernett , et al. December 1, 2 | 2020-12-01 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20200332024 - Desjarlais; John R. ; et al. | 2020-10-22 |
| Optimized Antibodies That Target Cd19 App 20200317804 - Bernett; Matthew J. ; et al. | 2020-10-08 |
| Heterodimeric proteins Grant 10,738,132 - Desjarlais , et al. A | 2020-08-11 |
| Targeted Heterodimeric Fc Fusion Proteins Containing Il-15/il-15ra And Nkg2d Antigen Binding Domains App 20200247862 - Kind Code | 2020-08-06 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20200199251 - Bernett; Matthew J. ; et al. | 2020-06-25 |
| Optimized antibodies that target CD19 Grant 10,626,182 - Bernett , et al. | 2020-04-21 |
| Heterodimeric antibodies that bind CD3 and CD38 Grant 10,526,417 - Bernett , et al. J | 2020-01-07 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20190202938 - Bernett; Matthew J. ; et al. | 2019-07-04 |
| Novel Ctla4-ig Immunoadhesins App 20190127437 - Lazar; Gregory A. ; et al. | 2019-05-02 |
| Heterodimeric antibodies that bind CD3 and tumor antigens Grant 10,259,887 - Bernett , et al. | 2019-04-16 |
| TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS App 20190016778 - Bernett; Matthew J. ; et al. | 2019-01-17 |
| CTLA4-Ig immunoadhesins Grant 10,155,800 - Lazar , et al. Dec | 2018-12-18 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20180305465 - Stevens; Jennitte Leann ; et al. | 2018-10-25 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180282432 - Bernett; Matthew J. ; et al. | 2018-10-04 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20180223000 - Bernett; Matthew J. ; et al. | 2018-08-09 |
| Optimized Antibodies That Target Cd19 App 20180148511 - Bernett; Matthew J. ; et al. | 2018-05-31 |
| Bispecific Antibodies That Bind to CD38 and CD3 App 20180094079 - Bernett; Matthew J. ; et al. | 2018-04-05 |
| Optimized Antibodies That Target Cd19 App 20180009900 - Bernett; Matthew J. ; et al. | 2018-01-11 |
| Heterodimeric antibodies to CD3 X CD123 Grant 9,856,327 - Bernett , et al. January 2, 2 | 2018-01-02 |
| Heterodimeric antibodies to CD3 X CD20 Grant 9,850,320 - Bernett , et al. December 26, 2 | 2017-12-26 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20170335013 - Desjarlais; John R. ; et al. | 2017-11-23 |
| Optimized antibodies that target CD19 Grant 9,803,020 - Bernett , et al. October 31, 2 | 2017-10-31 |
| Heterodimeric proteins Grant 9,701,759 - Desjarlais , et al. July 11, 2 | 2017-07-11 |
| Antibodies With Modified Isoelectric Points App 20170174757 - Lazar; Gregory ; et al. | 2017-06-22 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,617,348 - Desjarlais , et al. April 11, 2 | 2017-04-11 |
| Antibodies with modified isoelectric points Grant 9,605,061 - Lazar , et al. March 28, 2 | 2017-03-28 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081420 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Heterodimeric Antibodies To Cd3 X Cd123 App 20170081424 - Bernett; Matthew J. ; et al. | 2017-03-23 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,540,451 - Desjarlais , et al. January 10, 2 | 2017-01-10 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160355608 - Bernett; Matthew J. ; et al. | 2016-12-08 |
| Novel Ctla4-ig Immunoadhesins App 20160264643 - Lazar; Gregory A. ; et al. | 2016-09-15 |
| Heterodimeric Antibodies That Bind Cd3 And Tumor Antigens App 20160229924 - Bernett; Matthew J. ; et al. | 2016-08-11 |
| Heterodimeric Antibodies That Bind Cd3 And Cd38 App 20160215063 - Bernett; Matthew J. ; et al. | 2016-07-28 |
| Heterodimeric Antibodies Including Binding To Cd8 App 20160176969 - Bernett; Matthew J. ; et al. | 2016-06-23 |
| CTLA4-Ig immunoadhesins Grant 9,371,397 - Lazar , et al. June 21, 2 | 2016-06-21 |
| Antibodies With Modified Isoelectric Points And Immunofiltering App 20160068588 - Bernett; Matthew J. ; et al. | 2016-03-10 |
| Rapid Clearance Of Antigen Complexes Using Novel Antibodies App 20160060360 - Moore; Gregory L. ; et al. | 2016-03-03 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,266,966 - Desjarlais , et al. February 23, 2 | 2016-02-23 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,221,916 - Desjarlais , et al. December 29, 2 | 2015-12-29 |
| Compositions and methods for treating IgE-mediated disorders Grant 9,062,117 - Desjarlais , et al. June 23, 2 | 2015-06-23 |
| Optimized antibodies that target HM1.24 Grant 9,040,042 - Bernett , et al. May 26, 2 | 2015-05-26 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20150139985 - DESJARLAIS; JOHN ; et al. | 2015-05-21 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20150093379 - DESJARLAIS; JOHN ; et al. | 2015-04-02 |
| Novel Heterodimeric Proteins App 20140370013 - Desjarlais; John R. ; et al. | 2014-12-18 |
| Novel Heterodimeric Proteins App 20140294833 - Desjarlais; John R. ; et al. | 2014-10-02 |
| Antibodies With Modified Isoelectric Points App 20140249297 - LAZAR; Gregory A. ; et al. | 2014-09-04 |
| Optimized Antibodies That Target Hm1.24 App 20140205605 - Bernett; Matthew J. ; et al. | 2014-07-24 |
| Novel Ctla4-ig Immunoadhesins App 20140112924 - LAZAR; GREGORY A. ; et al. | 2014-04-24 |
| Optimized Antibodies That Target CD19 App 20140112916 - Bernett; Matthew J. ; et al. | 2014-04-24 |
| Optimized Antibodies That Target CD19 App 20140086906 - Bernett; Matthew J. ; et al. | 2014-03-27 |
| Antibodies with modified isoelectric points Grant 8,637,641 - Dahiyat , et al. January 28, 2 | 2014-01-28 |
| CTLA4-Ig immunoadhesins Grant 8,629,113 - Lazar , et al. January 14, 2 | 2014-01-14 |
| Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells Grant 8,551,485 - Bernett , et al. October 8, 2 | 2013-10-08 |
| Optimized antibodies that target CD19 Grant 8,524,867 - Bernett , et al. September 3, 2 | 2013-09-03 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20130203966 - DESJARLAIS; JOHN R. ; et al. | 2013-08-08 |
| NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS App 20130203967 - DESJARLAIS; JOHN R. ; et al. | 2013-08-08 |
| Novel Compositions and Methods for Treating IgE-Mediated Disorders App 20130177553 - Desjarlais; John ; et al. | 2013-07-11 |
| Method for Purifying Antibodies App 20130171095 - BERNETT; Matthew J. ; et al. | 2013-07-04 |
| Compositions and methods for treating IgE-mediated disorders Grant 8,435,517 - Desjarlais , et al. May 7, 2 | 2013-05-07 |
| Novel Ctla4-ig Immunoadhesins App 20130089550 - Lazar; Gregory A. ; et al. | 2013-04-11 |
| Optimized antibodies that target HM1.24 Grant 8,394,374 - Bernett , et al. March 12, 2 | 2013-03-12 |
| CTLA4-Ig immunoadhesins Grant 8,329,867 - Lazar , et al. December 11, 2 | 2012-12-11 |
| Human equivalent monoclonal antibodies engineered from nonhuman variable regions Grant 8,314,213 - Bernett , et al. November 20, 2 | 2012-11-20 |
| Optimized Antibodies That Target Cd19 App 20120082664 - Bernett; Matthew J. ; et al. | 2012-04-05 |
| Antibodies With Modified Isoelectric Points App 20120028304 - Dahiyat; Bassil I. ; et al. | 2012-02-02 |
| Antibodies That Specifically Bind to DR3 App 20120014950 - Migone; Thi-Sau ; et al. | 2012-01-19 |
| Novel Ctla4-ig Immunoadhesins App 20110287032 - Lazar; Gregory A. ; et al. | 2011-11-24 |
| Optimized CD40 Antibodies and Methods of Using the Same App 20110027276 - Bernett; Matthew J. ; et al. | 2011-02-03 |
| Optimized Antibodies that Target CD19 App 20100272723 - Bernett; Matthew J. ; et al. | 2010-10-28 |
| Method of treatment using adiponectin variants Grant 7,749,956 - Zalevsky , et al. July 6, 2 | 2010-07-06 |
| Adiponectin variants Grant 7,709,607 - Zalevsky , et al. May 4, 2 | 2010-05-04 |
| Optimized Antibodies that Target HM1.24 App 20100104557 - Bernett; Matthew J. ; et al. | 2010-04-29 |
| Pharmaceutical compositions of adiponectin variants and methods of storage Grant 7,678,886 - Zalevsky , et al. March 16, 2 | 2010-03-16 |
| Human Equivalent Monoclonal Antibodies Engineered From Nonhuman Variable Regions App 20100004431 - Bernett; Matthew J. ; et al. | 2010-01-07 |
| Globular adiponectin variants Grant 7,592,423 - Zalevsky , et al. September 22, 2 | 2009-09-22 |
| Optimized Ca9 Antibodies And Methods Of Using The Same App 20090162382 - Bernett; Matthew J. ; et al. | 2009-06-25 |
| Optimized Antibodies That Target Cd19 App 20080260731 - Bernett; Matthew J. ; et al. | 2008-10-23 |
| Optimized CD5 antibodies and methods of using the same App 20080254027 - Bernett; Matthew J. ; et al. | 2008-10-16 |
| Optimized Antibodies That Target Hm1.24 App 20080219974 - Bernett; Matthew J. ; et al. | 2008-09-11 |
| Optimized Cd40 Antibodies And Methods Of Using The Same App 20080199471 - Bernett; Matthew J. ; et al. | 2008-08-21 |
| Rational Chemical Modification of Adiponectin Variants App 20070054359 - Zalevsky; Jonathan ; et al. | 2007-03-08 |
| Adiponectin variants App 20070010659 - Zalevsky; Jonathan ; et al. | 2007-01-11 |
| Globular Adiponectin Variants App 20060281151 - Zalevsky; Jonathan ; et al. | 2006-12-14 |
| Pharmaceutical Compositions of Adiponectin Variants and Methods of Storage App 20060276395 - Zalevsky; Jonathan ; et al. | 2006-12-07 |
| Method of Treatment Using Adiponectin Variants App 20060270598 - Zalevsky; Jonathan ; et al. | 2006-11-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 